Phosphatidic acid (PA) is produced rapidly in agonist-stimulated cells, but the physiological function of this PA is unknown. We have examined the effects of PA on distinct isoforms of protein kinase C (PKC) using a new cell-free assay system. Addition of PA to cytosol from COS cells overexpressing PKC-a, -e or -d ifferentially activated all three isotypes, as shown by PKC autophosphorylation, and prominent phosphorylation of multiple endogenous substrates. In the absence of Ca2 , the diacylglycerol-insensitive C-isotype of PKC was most strongly activated by both PA and bisPA, a newly identified product of activated phospholipase D, with each lipid inducing its own profile of protein phosphorylation. BisPA was also a strong activator of PKC-e, but a weak activator of PKC-ax. Ca2+, at > 0
INTRODUCTION
Phosphatidic acid (PA) is rapidly produced in receptorstimulated cells through activation of phospholipase D (PLD) and/or the concerted action of phospholipase C (PLC) and diacylglycerol (DG) kinase (Billah and Anthes, 1990; Exton, 1990; van Blitterswijk et al., 1991a,b; van der Bend et al., , 1994 Pacini et al., 1993) . Several observations suggest that PA may act as a second messenger. For example, in neutrophils, agonist-induced production of PA, rather than DG, closely correlates with secretion and superoxide generation (Cockcroft, 1984; Bauldry et al., 1992) ; in other cell systems, PA generated by either receptor stimulation or exogenous PLD induces hormone release (Liscovitch and Amsterdam, 1989; Metz and Dunlop, 1990) . PA generated by ADP-ribosylation factoractivated PLD is thought to play a role in intracellular membrane traffic (Brown et al., 1993; Kahn et al., 1993; Cockcroft et al., 1994) . When added exogenously to cells, PA exhibits growth factor-like activities (Moolenaar et al., 1986; Imagawa et al., 1989; and can induce actin polymerization (Ha and Exton, 1993) , but cellular targets for PA (either intracellular or at the cell surface) have not been identified to date. Studies in vitro indicate that PA can activate several enzymes including PtdIns4P kinase (Moritz et al., 1992) , protein kinase C (PKC; Lee and Bell, 1989; Epand et al., 1992; PKC-e activation. In contrast, PKC-a was strongly activated by PA only in the presence of Ca2+. BisPA-induced phosphorylations mediated by PKC-~could be mimicked in part by other acidic phospholipids and unsaturated fatty acids. PA activation of PKC-~was unique in that PA not only stimulated PKC-Cmediated phosphorylation of distinctive substrates, but also caused an upward shift in electrophoretic mobility of PKC-C, which was not observed with other acidic lipids or with PKC-ac or -e. We have presented evidence that this mobility shift is not caused by PKC-C autophosphorylation, but it coincides with physical binding of PA to PKC-C. These results suggest that in cells stimulated under conditions where intracellular Ca2+ is at (or has returned to) basal level, PA may be a physiological activator of PKC-C.
and Exton, 1992 ) and a cytosolic protein tyrosine phosphatase (Zhao et al., 1993) . Furthermore, Bocckino et al. (1991) have reported that PA can stimulate protein phosphorylation in cytosolic extracts from various rat organs, but the identity of the PA-sensitive kinase(s) remains unknown.
In this study, we have examined the effects of PA on the activity of distinct PKC isotypes using a COS cell expression system. The PKC family consists of at least ten different isozymes (Stabel and Parker, 1991; Nishizuka, 1992) , which can be divided into three distinct subgroups on the basis of their biochemical and structural properties: (1) the 'classical' isoforms, regulated by Ca2' and DG plus phosphatidylserine (PS), comprising PKC-a, -/h, -fI11 and -y; (2) the 'new' isoforms PKC-e, -d, -y and -6, which lack the Ca2l-binding domain; and (3) the ' atypical' isoforms PKC-C, -t and -,t, which differ from the others in that they are Ca2+-and DG-independent and refractory to phorbol ester activation (Ono et al., 1989; Gschwendt et al., 1992; Liyanage et al., 1992; Ways et al., 1992; Nakanishi and Exton, 1992; Selbie et al., 1993; Johannes et al., 1994) . The physiological activator(s) of the last PKC isotypes have not been identified, although in vitro studies suggest that purified PKC-c an be activated by Ptdlns(3,4,5)P3 (Nakanishi et al., 1993) .
In previous studies on PKC activation, workers have incubated purified PKCs with various lipids and artificial substrates. In our present study we have utilized cytosols prepared from COS cells Davis et al., 1989) was kindly provided by Roche Research Center (Welwyn Garden City; U.K.).
Antibodies
Antibodies against PKC-a, -e, -C and c-raf-1 were raised in rabbits, and were directed against oligopeptides based on the Ctermini of these proteins (Schultz et al., 1985; Marais and Parker, 1989; Schaap et al., 1989; Ways et al., 1992) .
cDNA constructs pmtM is a pMT-2-derived COS cell expression vector that contains a multiple cloning region (Gebbink et al., 1991) ; pmtSM is derived from pmtM and contains three upstream stop codons in all three reading frames (to be described elsewhere). pmtM-PKC-a contains bovine PKC-ac (Schaap et al., 1993) . pMT2-PKC-e contains mouse PKC-e (Schaap et al., 1989) ; rat PKC-C cDNA (Ways et al., 1992) which is considered to be a reliable measure of PKC activation (Mitchell et al., 1989) . Figure 2 shows autophosphorylation of the various PKCs in COS cytosols treated with either PA or PS/DG, followed by immunoprecipitation. In the nominal absence of free Ca2+, PKC-a shows hardly any lipid-induced Using artificial substrates, Nakanishi and Exton (1992) reported that various acidic lipids can activate purified PKC-~in vitro. We used cytosols from transfected COS cells to test whether acidic lipids other than PA, in particular the novel phospholipid bisPA, could induce PKC-C-mediated phosphorylation of endogenous substrates. Figure 3 shows that bisPA, PS (with or without DG), lysoPA (LPA), PI, phosphatidylglycerol (PG), cardiolipin (CL) and cis-unsaturated fatty acids induce phosphorylation of a number of endogenous substrates to different degrees. BisPA consistently induces the strongest substrate phosphorylation pattern, at an even lower concentration than for other lipids tested. The most prominent PKC-~substrates are proteins of apparent molecular masses of 27, 30, 52, 58 and 78 kDa. The last protein is PKC-~itself, as will be shown below. Phosphorylation of the 27 kDa protein is consistently much more pronounced with PA as an activator. Figure 3 further shows that cisunsaturated fatty acids, notably oleic acid (18: 1) and arachidonic acid (20: 4), can activate PKC-~, whereas the saturated ones such as stearic (18:0) and palmitic acid (16:0) are ineffective, even when added at very high concentrations (results not shown). This result agrees, at least qualitatively, with the in vitro data of Nakanishi and Exton (1992) , who used purified PKC-C. Importantly, it is seen that DG fails to activate PKC-~ (Figure 3 ), a result in agreement with previous reports (see the Introduction section); phorbol ester (results not shown), ceramide, PC and phosphatidylethanolamine (PE) are also ineffective. Finally, deoxycholate (DOC) fails to mimic the action of PA and bisPA, which argues against a non-specific detergent-like effect of the lipids tested. Figure 4 illustrates the PA and bisPA dose dependencies of PKC-(-mediated phosphorylations. On a molar basis, bisPA is found to be maximally active at a 3-to 6-fold lower concentration than PA in triggering PKC-(-mediated protein phosphorylation. Figure 4 also emphasizes the differential substrate preference imposed by PA and bisPA; for example, compare the 27 and 52 kDa phosphoproteins induced by PA with the 30 and 58 kDa phosphoproteins induced by bisPA. BisPA is also a strong activator of PKC-e-mediated phosphorylation, particularly of the 30 kDa substrate, but is only a weak activator of PKC-ac (results not shown).
Ca2+ inhibits PKC-C activation
Since Ca2l is essential for PA activation of PKC-a (Figures 1 and  2 ), we thought this was likely to be due to the occurrence of the Ca2+ binding (C2) domain in the primary structure of this isotype. In agreement with this notion, activation of purified PKC-e or -~, which both lack such a Ca2+ binding domain, was previously found to be independent of Ca2+ or even inhibited at millimolar Ca2+ concentrations (Schaap and Parker, 1990; Nakanishi and Exton, 1992) . In the COS cell lysates, we found that PA-(and bisPA)-activation of PKC-e is also independent of Ca2+ (results not shown). Unexpectedly, however, PA or bisPA activation of PKC-~in this cell-free system is inhibited by Ca2+ (at > 0.1 ,uM) in a dose-dependent fashion ( Figure 5 ). Apparently, the cell-free system differs in this respect from an assay with purified PKC-< and an artificial substrate, peptide e (Nakanishi and Exton, 1992).
PA, but not other lipids, induces an electrophoretic mobility shift of PKC-C Figure 4 shows that in PKC-C-overexpressing cells, PA-induced phosphorylation of the 78 kDa protein is accompanied by a reduced electrophoretic mobility (to 80-82 kDa apparent molecular mass) in a dose-dependent fashion. Such a mobility shift is not seen with bisPA or any other lipid, even at the highest concentrations tested (Figures 3 and 4) . This 78 kDa protein is PKC-itself, as revealed by immunodepletion experiments (Figure 6 ). Moreover, this protein band is not detected in cells transfected with either empty vector or other PKC isotypes (Figure 1 and results not shown). A plausible explanation for the PA-induced mobility shift of PKC-G would be its autophosphorylation. We have examined this possibility using a highly selective PKC inhibitor, Ro 31-8220 (Davis et al., 1989; Walker and Watson, 1993) . Ro 31-8220 (3 ,uM) effectively inhibits PKC-C-mediated phosphorylation of endogenous substrates (Figure 7a ) as well as PKC-autophosphorylation (as seen in PKC-immunoprecipitates; Figure 7b ), although some weak PA-induced autophosphorylation still remains visible. Despite the dramatic reduction of PKC-autophosphorylation in the presence of Ro 31-8220, the PA-induced gel-shift of PKC-C is still present, as analysed by immunoblotting (Figure 7c ). In contrast, no shift is observed when PA is added to PKC-c or -e-containing cytosols (Figure 7d ). The Western blot (Figure 7c ) further shows that PKC-protein levels are virtually the same in all samples, implying that the dramatic reduction in radioactivity recovered in immunoprecipitates of Ro 31-8220-treated samples (first two lanes of Figure 7b) PtdIns(4,5)P2 and a-actinin and for the binding of lysoPA to serum albumin (Tigyi et al., 1990 Figure 4 ) and assuming enhanced PA concentrations of 360 ,tg/ml in agonist-stimulated cells, as estimated by Bocckino et al. (1991) . PKC-G is ubiquitously expressed, but very little is known about its normal physiological function. Recent evidence suggests that PKC-C has a critical but as yet undefined role in mitogenic signalling (Berra et al., 1993) . This raises the possibility that the mitogenic action in fibroblasts of exogenous PA or bacterial PLD (Moolenaar et al., 1986; may be explained by PA activation of PKC-C. To this end, exogenous PA must be incorporated in monomeric form in the outer leaflet of the plasma membrane lipid bilayer and undergo transbilayer diffusion ('flipping') (Tokumura et al., 1992) or be internalized into cells by some other mechanism. Of note is that intracellular accumulation of PA, rather than an increase in DG, correlates well with mitogenesis in growth factor-stimulated fibroblasts Khan et al., 1993; Kochs et al., 1993; Nakanishi et al., 1993) . These findings raise questions about the physiological relevance of these multiple activators. Since some of these compounds are produced at different time points during cell stimulation, it has been hypothesized that they may keep PKC active for a prolonged time period, which might be essential for long-term responses, such as cell proliferation and differentiation (Nishizuka, 1992) . Alternatively, distinct PKC isotypes may be differentially regulated by lipids Khan et al., 1993; Nakanishi et al., 1993) (Singh et al., 1993) .
That PKC-C is activated by other acidic lipids as well ( Figure   3 ) is consistent with previous data obtained with purified PKC-C (Nakanishi and Exton, 1992) . Of special interest are the effects of the novel phospholipid bisPA. BisPA is rapidly generated in stimulated fibroblasts as the product of a PLD-mediated transphosphatidylation reaction that uses DG as the acceptor for the phosphatidyl moiety (van Blitterswijk and Hilkmann, 1993 Isoform-dependent differences in substrate phosphorylation have, so far, been described mainly for artificial substrates . Our results that at least two substrates, of 27 kDa and 52 kDa, are phosphorylated by PA-stimulated PKC-( and -a (the latter only with Ca2l) but not by PKC-e (Figure 1 ), are one of the few demonstrations of a difference in endogenous substrate preference among PKC isoforms (Majumdar et al., 1991; Nishikawa et al., 1992) .
In conclusion, our results demonstrate a unique interaction between PA and PKC-C, which is not found for other PKC isotypes or for the other PKC-C activators tested; PA activates PKC-C, as inferred from its autophosphorylation, and evokes a unique pattern of phosphorylated substrates, the identification of which should help to clarify the role of PKC-C in cellular signalling. PA-activated PKC-C may provide the link between receptor-stimulated PLD and the cellular actions of PA. Thus, PA must be considered, as a candidate physiological activator of PKC-(.
